期刊
CRITICAL CARE RESEARCH AND PRACTICE
卷 2017, 期 -, 页码 -出版社
HINDAWI LTD
DOI: 10.1155/2017/3635609
关键词
-
Polymyxin B has resurged in recent years as a last resort therapy for Gram-negative multidrug-resistant (MDR) and extremely drug resistant (XDR) infections. Understanding newer evidence on polymyxin B is necessary to guide clinical decision making. Here, we present a literature review of polymyxin B in Gram-negative infections with update on its pharmacology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据